Xeraya Capital
Venture capitalKuala Lumpur · Seed–Growth · 17 people tracked
Investment thesis
Xeraya focuses on global life sciences investments with a commitment to long-term partnerships and local value creation. The firm invests in medical technologies for diagnosis, monitoring, and treatment; pharmaceutical biotech companies from early-stage platform technologies through clinical stages, including drug delivery innovations; and biorenewables and agtech platforms that displace traditional processes and reduce environmental impact. As a Shariah-compliant venture investor, Xeraya provides both venture and growth equity financing alongside active board representation and operational support. The firm is a PRI signatory committed to integrating ESG considerations and contributing to UN Sustainable Development Goals.
Source: firm website, verified Jul 21, 2026.
Team · 17 people
from the firm's websiteFounding team member with over 20 years of experience in financing new ventures, corporate investing, and international expansion in life sciences and technology industries.
Brings extensive life sciences expertise and strong business networks, particularly in Europe.
Joined as SVP with over 15 years of experience across life sciences research, academia, management, and policy-making.
Senior Vice President with experience spanning both private equity and venture capital investments.
Joined in 2016 with over 10 years of experience in life sciences investments, specifically in healthcare and economic development initiatives.
Joined in 2012 with diverse background spanning biotechnology, intellectual property, and business management.
Joined in January 2016 with extensive business leadership experience in pharmaceuticals, medical technology, and digital health, with strong networks in the United States.
Brings expertise in medical device manufacturing, commercialization, and venture partnering with established networks throughout the Asia Pacific region.
Advisor who joined Xeraya in February 2015 with extensive chemical industry experience and strong business networks across the Asia Pacific region.
A founding member of Xeraya who brings accumulated expertise in technology investment, management consulting, corporate strategy, and operations.
Senior Vice President with over 10 years of experience in transaction advisory, regulatory, and external audit work with international exposure including Bermuda.
Investment professional with experience in early education, social infrastructure, healthcare, and climate research deals, along with financial modeling and value creation capabilities.
Joined in 2016 with accounting experience across multiple small and medium enterprises from diverse industries.
What they invest in
from 1 of 2 portfolio companiesBiotech ×1Climate Tech ×1Healthtech ×1
Investments · 2 tracked
founders shown can be your intro pathSpruce Capital Partners creates, advises, and invests in life sciences companies that make positive environmental impacts and improve human health and wellness.
BiotechClimate TechHealthtech
Frequently asked questions
- What stage does Xeraya Capital invest at?
- Xeraya Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Xeraya Capital focus on?
- Xeraya Capital focuses on AgTech, Biotech, Cleantech, Medical Devices.
- Where is Xeraya Capital located?
- Xeraya Capital is headquartered in Kuala Lumpur, MY.
- Does Xeraya Capital lead rounds?
- Yes, Xeraya Capital leads investment rounds.
Similar investors
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Osage University Partners is a venture capital firm founded in 2009 that invests in breakthrough startups emerging from leading research labs and university innovation ecosystems. The firm focuses on technology (software, hardware, climate tech) and life science (therapeutics, medtech, diagnostics, research tools) companies across all stages from pre-seed through crossover, leveraging partnerships with over 150 universities and research institutions globally.
Novo Holdings is a holding and investment company managing the assets of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. The firm invests in life science companies across all development stages and manages a diversified portfolio including equities, bonds, real estate, infrastructure, and private equity.